Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy

Asian Journal of Surgery

Volumn 31, Issue 2, 2008, Pages 41-49

  Cheung, Yue Sun ^a   Chan, Henry L Y ^a   Wong, John ^a   Lee, Kit Fai ^a   Poon, Terence C W ^a   Wong, Nathalie ^a   Lai, Paul B S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatitis activity; Hepatitis B; Hepatocellular carcinoma; Recurrence; Survival

Indexed keywords

EID: 44949102254     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/S1015-9584(08)60056-1     Document Type: Article

References (25)

1. Leong TYM, Leong ASY. Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB 2005;7:5-15.
2. Broelsch CE, Frilling A, Malago M. Hepatoma-resection or transplantation. Surg Clin N Am 2004;84:495-511.
3. John AR, Khan S, Mirza DF, et al. Multivariate and univariate analysis of prognostic factors following resection in HCC: the Birmingham experience. Dig Surg 2006;23:103-9.
4. Park JH, Koh KC, Choi MS, et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 2006;192:29-33.
5. Lau WY. Future perspectives for hepatocellular carcinoma. HPB 2003;5:206-13.
6. Ko S, Nakajima Y, Kanehiro H, et al. Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg 1996;20:1082-6.
7. Ko S, Nakajima Y, Kanehiro H, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg 1996;224:591-5.
8. Yamanaka N, Takada M, Tanaka T, et al. Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report. J Gastroenterol 2000;35:106-13.
9. Malcolm B, Lauwers GY, Doherty CA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001;136:528-35.
10. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinoma. Ann Surg 2002;235:722-31.
11. Ko S, Kanehiro H, Hisanaga M, et al. Liver fibrosis increases the risk of intra-hepatic recurrence after hepatectomy for hepatocellular carcinoma. BJS 2002;89:57-62.
12. Nanashima A, Tanaka K, Yamaguchi H, et al. Fibrosis and inflammatory activity in non-cancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Dig Dis Sci 2003;48:1517-22.
13. Standish RA, Cholongitas E, Dhillon A, et al. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006;55:569-78.
14. Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 2005;25:472-89.
15. ter Borg F, ten Kate FJW, Cuypers HTM, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 1998;351:1914-8.
16. Chan HLY, Tsang SWC, Liew CT, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histologic liver damage in HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2002;97:406-12.
17. Tarao K, Rino Y, Ohkawa S, et al. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer 2002;94:1787-95.
18. Tarao K, Takemiya S, Tamai S, et al. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 1997;79:688-94.
19. Tarao K, Rino Y, Takemiya S, et al. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology 2000;43:20-6.
20. Heathcote EJ. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 2004;127:S294-302.
21. Chan HLY, Sung JJY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 2006;26:153-61.
22. Chung YH, Kim JA, Song BC, et al. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma. Cancer 2000;89:977-82.
23. Shi B, Wang X, Yang Z. Vascular endothelial growth factors and liver disease. Hepatogastroenterology 2001;48:1145-8.
24. Sugimachi K, Maehara S, Tanaka S, et al. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2001;8:410-6.
25. Sung JJ, Chan HL, Wong ML, et al. Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients. J Viral Hepat 2002;9:229-34.